DWS


Disappointing Q4 22 figures, 2025 targets confirmed

02/02/23 -"• Net profit decreased by 57% to €111m for Q4 22 compared to Q4 21 • Net new money outflow was €1.6bn in Q4 22 compared to an inflow of €15bn for Q4 21. • Net profit was down by 23% to €599m for ..."

Pages
47
Language
English
Published on
02/02/23
You may also be interested by these reports :
03/07/25
Pluxee’s Q3 revenue met expectations and was on track towards the unchanged FY guidance, aiming to continue benefiting from its active M&A strategy. ...

02/07/25
Following Exor’s reclassification as an “Investment Entity” under IFRS 10, we no longer include equity-accounted results in our estimates. Under this ...

30/06/25
We have downgraded both our 2025 (-9%) and our 2026 (-12%) EPS projections. For 2025, our EPS estimates have been revised down mostly owing to lower ...

30/06/25
Prosus is done waiting. At its Capital Markets Day, the group unveiled an ambitious roadmap to double revenues by 2028, scaling food, fintech, and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO